title: Building a structured monitoring and evaluating system of postmarketing drug use in Shanghai.
abstract: In order to understand a drug's full profile in the post-marketing environment, information is needed regarding utilization patterns, beneficial effects, ADRs and economic value. China, the most populated country in the world, has the largest number of people who are taking medications. To begin to appreciate the impact of these medications, a multifunctional evaluation and surveillance system was developed, the Shanghai Drug Monitoring and Evaluative System (SDMES). Set up by the Shanghai Center for Adverse Drug Reaction Monitoring in 2001, the SDMES contains three databases: a population health data base of middle aged and elderly persons; hospital patient medical records; and a spontaneous ADR reporting database. Each person has a unique identification and Medicare number, which permits record-linkage within and between these three databases. After more than three years in development, the population health database has comprehensive data for more than 320,000 residents. The hospital database has two years of inpatient medical records from five major hospitals, and will be increasing to 10 hospitals in 2007. The spontaneous reporting ADR database has collected 20,205 cases since 2001 from approximately 295 sources, including hospitals, pharmaceutical companies, drug wholesalers and pharmacies. The SDMES has the potential to become an important national and international pharmacoepidemiology resource for drug evaluation.
authors.affiliation: Shanghai Center for Adverse Drug Reaction Monitoring, Shanghai, China.
authors.forename: Wenmin
authors.initials: W
authors.lastname: Du
authors.forename: Mitchell
authors.initials: M
authors.lastname: Levine
authors.forename: Longxing
authors.initials: L
authors.lastname: Wang
authors.forename: Yaohua
authors.initials: Y
authors.lastname: Zhang
authors.forename: Chengdong
authors.initials: C
authors.lastname: Yi
authors.forename: Hongmin
authors.initials: H
authors.lastname: Wang
authors.forename: Xiaoyu
authors.initials: X
authors.lastname: Wang
authors.forename: Hongjuan
authors.initials: H
authors.lastname: Xie
authors.forename: Jianglong
authors.initials: J
authors.lastname: Xu
authors.forename: Huilin
authors.initials: H
authors.lastname: Jin
authors.forename: Tongchun
authors.initials: T
authors.lastname: Wang
authors.forename: Gan
authors.initials: G
authors.lastname: Huang
authors.forename: Ye
authors.initials: Y
authors.lastname: Wu
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D002681:China; D019992:Databases as Topic; D011358:Product Surveillance, Postmarketing